Fig. 4
The correlation between the risk signature and different clinicopathological features. A 7 FIRLs expression profiles and correlation between prognostic signature and clinicopathological features. *P < 0.05; **P < 0.01; ***P < 0.001. B–M The survival differences between high- and low-risk groups stratified by clinical variables: B, C age (≤ 65 and > 65), D, E gender (female and male), F, G tumor stage (I, II and IV), H, I T stage (T1–2 and T3–4), J, K N stage (N0 and N1–3), and L, M M stage (M0 and M1). FIRLs ferroptosis and iron-metabolism related lncRNAs